(Q40818319)

24 September 2017

title

Elimination of latently HIV-1-infected cells by lymphoblasts armed with bifunctional antibody (English)

1 reference

24 September 2017

Yin S

1

1 reference

24 September 2017

Okada N

series ordinal

2

1 reference

24 September 2017

Okada H

series ordinal

3

1 reference

24 September 2017

language of work or name

1 reference

1 January 2001

1 reference

Microbiology and Immunology

24 September 2017

published in

1 reference

24 September 2017

volume

45

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

101-108

1 reference

Bispecific antibodies that mediate killing of cells infected with human immunodeficiency virus of any strain

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Bispecific antibody targeting of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 to human macrophages through the Fc IgG receptor I mediates neutralizing effects in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Functional consequences of macrophage infection by human immunodeficiency virus: bispecific antibody targeting of HIV-1-infected cells to Fc gamma RI expressing effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Specific cytolysis of HIV-infected cells by lymphocytes armed with bifunctional antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Elimination of HIV-infected cells by lymphocytes armed with a bifunctional antibody to gp120 of HIV and CD3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

AIDS virus-specific cytotoxic T lymphocytes in lung disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Targeting of cytotoxic cells with heterocrosslinked antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Enhanced HIV replication in monocytic cells following engagement of adhesion molecules and contact with stimulated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

The role of the T3/antigen receptor complex in T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

HIV-specific cytotoxic T lymphocytes in seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB01266.X

10.1111/J.1348-0421.2001.TB01266.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference